---
title: "CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2026 Financial Results"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294735797.md"
description: "In Zug, Switzerland and Boston, financial results for the second quarter ending on June 30, 2026 were reported by CRISPR Therapeutics (Nasdaq: CRSP)."
datetime: "2026-08-03T20:18:34.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294735797.md)
  - [en](https://longbridge.com/en/news/294735797.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294735797.md)
---

# CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2026 Financial Results

In Zug, Switzerland and Boston, financial results for the second quarter ending on June 30, 2026 were reported by CRISPR Therapeutics (Nasdaq: CRSP).

### Related Stocks

- [CRSP.US](https://longbridge.com/en/quote/CRSP.US.md)

## Related News & Research

- [Brave Asset Management Inc. Cuts Stake in CRISPR Therapeutics AG $CRSP](https://longbridge.com/en/news/295199690.md)
- [Gil Blum Reiterates Buy on CRISPR Therapeutics, Maintains $82 Price Target on Pipeline Upside and 2026 Data Catalysts](https://longbridge.com/en/news/290700939.md)
- [Apple declares Q3 2026 distribution of R$ 0.05 per unit, payable Aug. 19](https://longbridge.com/en/news/296137926.md)
- [Synchrony Financial declares dividend of R$ 1.2 per unit for 3Q 2026](https://longbridge.com/en/news/296392496.md)
- [CTO Realty Growth declares USD 0.38 common dividend for Q3 2026](https://longbridge.com/en/news/296394656.md)